Table 3.

Serum b-FGF and VEGF concentrations in GO patients (active GO and inactive GO), GD patients, and the control group (NC) (mean ± SD)

Growth factors	Active GO (n = 34)	Inactive GO (n = 14)	GD (n = 30)	Normal control (n = 30)
VEGF(pg/ml)	182.76 ± 75.17c e	132.34 ± 42.19b	125.46 ± 34.82c d	76.45 ± 6.81f
b-FGF(pg/ml)	101.52 ± 35.53c e	78.58 ± 17.37a	75.38 ± 13.53b d	63.71 ± 7.40e

–vs. controls, ^a P < 0.05, ^b P < 0.01, ^c P < 0.001;

–vs. Inactive GO, ^d P > 0.05, ^e P < 0.05, ^f P < 0.01;